(Q35183776)

7 August 2017

1 reference

title

Insulin lispro: a useful advance in insulin therapy (English)

1 reference

7 August 2017

1 reference

Simon Heller

1

0 references

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Expert Opinion on Pharmacotherapy

7 August 2017

published in

1 reference

7 August 2017

volume

4

1 reference

7 August 2017

issue

8

1 reference

7 August 2017

page(s)

1407-1416

1 reference

Insulin analogs with improved pharmacokinetic profiles

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

Action profiles of fast onset insulin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

Effectiveness of postprandial Humalog in toddlers with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

Use of lispro insulin and quality of life in adolescents on intensive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

Retinopathy risk: what is responsible? Hormones, hyperglycemia, or humalog? Response to Kitzmiller et al.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

Metabolic and immunologic effects of insulin lispro in gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

The human insulin analogue insulin lispro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

Monomeric insulins obtained by protein engineering and their medical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1407

10.1517/14656566.4.8.1407

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference